Yogic Breathing Exercises for ALS

HY
Overseen ByHon Yuen, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial explores whether a 6-week virtual yogic breathing program can help individuals with ALS (amyotrophic lateral sclerosis) improve breathing, speech, and emotional well-being. Participants will either engage in this breathing program or continue their usual activities. It suits individuals diagnosed with ALS or myasthenia gravis who can follow multi-step instructions and have internet access for virtual sessions. As an unphased trial, this study provides a unique opportunity to explore innovative approaches to enhance the quality of life for those with ALS.

Will I have to stop taking my current medications?

The trial requires that participants have been on a stable dose of their medications for more than 60 days, so you will not need to stop taking your current medications.

What prior data suggests that these yogic breathing exercises are safe for people with ALS?

Research has shown that breathing exercises used in yoga are generally safe for people. A review of various yoga studies found no serious safety issues with these exercises. Participants can expect these breathing exercises to be manageable, with little risk of side effects.12345

Why are researchers excited about this trial?

Researchers are excited about this trial because it explores the potential benefits of yogic breathing exercises for people with ALS, a condition that typically relies on medications like Riluzole and Edaravone to manage symptoms. Unlike these standard drug treatments, yogic breathing is a non-pharmacological approach that may improve respiratory function and overall well-being without the risk of medication side effects. This technique is also accessible and can be practiced virtually, offering a convenient and potentially more holistic way to support those living with ALS. By investigating this method, researchers hope to discover complementary strategies that enhance quality of life alongside traditional medical treatments.

What evidence suggests that yogic breathing exercises might be an effective treatment for ALS?

This trial will compare the effects of yogic breathing exercises with a waitlist control group. Research has shown that exercise, including breathing exercises, can strengthen muscles in people with ALS. A long-term study found that a patient with a specific type of ALS had much stronger breathing muscles after following a breathing strength training program. Additionally, moderate daily exercise can slow movement loss, reduce fatigue, and lessen pain in people with ALS. Although specific data on yogic breathing exercises is limited, their focus on controlled breathing might enhance these benefits. Overall, exercise programs appear promising for improving some physical abilities in people with ALS.12367

Who Is on the Research Team?

Hon K. Yuen, PhD, OTR/L - SHP ...

Hon K Yuen, PhD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults over 18 with ALS who can use the internet and follow instructions. They should be able to speak, have a certain level of lung function (FVC ≥70%), and not expect to live less than 6 months. They shouldn't be in another study or have severe hearing or vision problems.

Inclusion Criteria

I can understand and follow complex instructions.
I have been on a consistent dose of my ALS medication for over 60 days.
Access to internet and a computer or smartphone that can perform videoconferencing
See 3 more

Exclusion Criteria

You are expected to live for less than 6 months.
You have difficulty hearing or seeing that makes it hard for you to do breathing exercises online.
Current participation in another clinical trial during the study period that can affect the outcomes of the study

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants engage in a 6-week virtual yogic breathing exercise program (YBEP) with 1-3 sessions per week

6 weeks
6 weekly virtual sessions

Follow-up

Participants are monitored for the maintenance of improvements in breathing, speech function, and emotional well-being

3 months

What Are the Treatments Tested in This Trial?

Interventions

  • Yogic Breathing Exercise
Trial Overview The trial tests a virtual yogic breathing exercise program over six weeks, aiming to improve breathing, speech, and emotional well-being in people with ALS.
How Is the Trial Designed?
2Treatment groups
Experimental Treatment
Active Control
Group I: Yogic breathing exerciseExperimental Treatment1 Intervention
Group II: Waitlist controlActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

In a pilot study involving 20 ALS patients, those who used POWERbreathe® inspiratory muscle training alongside usual care showed significant improvements in maximum inspiratory pressure (PImax) and heart rate compared to the control group, indicating enhanced respiratory function.
The experimental group also experienced better quality of life and functionality, as evidenced by increased scores on the ALS Functional Rating Scale, suggesting that inspiratory muscle training could be a beneficial addition to standard care for ALS patients.
POWERbreathe® Inspiratory Muscle Training in Amyotrophic Lateral Sclerosis.Vicente-Campos, D., Sanchez-Jorge, S., Chicharro, JL., et al.[2023]
In a study of 20 ALS patients and 20 healthy volunteers, it was found that patients with bulbar symptoms exhibited abnormal laryngeal movements during mechanical insufflation-exsufflation (MI-E), which compromised their ability to cough effectively.
Customizing MI-E settings for individual patients, especially those with bulbar symptoms, could enhance the effectiveness of this non-invasive treatment by addressing the observed laryngeal adduction that limits airway size during the procedure.
Laryngeal response patterns influence the efficacy of mechanical assisted cough in amyotrophic lateral sclerosis.Andersen, T., Sandnes, A., Brekka, AK., et al.[2018]
In a study of 26 early-affected ALS patients, specific inspiratory muscle training did not show significant differences in overall outcomes compared to a placebo exercise program over eight months.
However, within-group analysis indicated that inspiratory exercise may lead to temporary improvements in certain respiratory functions, suggesting that further investigation into exercise regimes for ALS patients is warranted.
Respiratory exercise in amyotrophic lateral sclerosis.Pinto, S., Swash, M., de Carvalho, M.[2022]

Citations

Yogic Breathing Exercise for People With Amyotrophic ...The aim of this study is to understand how well a 6-week virtual yogic breathing exercise program (YBEP) will improve breathing, speech, and emotional well- ...
Yogic Breathing Exercises for ALS · Info for ParticipantsA 24-month respiratory strength training program significantly improved inspiratory and expiratory muscle strength in a patient with C9orf72 amyotrophic ...
Trial: Yogic Breathing Exercise for People With Amyotroph...The aim of this study is to understand how well a 6-week virtual yogic breathing exercise program (YBEP) will improve breathing, speech, and ...
Effects of Physical Activity on Amyotrophic Lateral Sclerosis[32] showed that a moderate daily exercise program decreased the loss of motor function, fatigue, and pain of ALS patients after 6 months. Improvements in motor ...
The effect of exercise intervention on amyotrophic lateral ...Meta-analysis results show that exercise intervention can significantly improve the overall function, walking test (WT) distance and maximum expiratory ...
Meditation Training for People with Amyotrophic Lateral ...We believe our protocol is open to all ALS patients whose diagnosis occurred no more than 18 months earlier and who have an Amyotrophic Lateral Sclerosis ...
Proceedings of the 24th Annual NEALS Meeting - 2025... amyotrophic lateral sclerosis (ALS), with global safety reviews conducted since approval. Objective: Use postmarketing pharmacovigilance data ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security